Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV005001713 | SCV005626880 | uncertain significance | not provided | 2024-07-09 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV005353370 | SCV006013307 | uncertain significance | Inborn genetic diseases | 2025-02-12 | criteria provided, single submitter | clinical testing | The c.1369A>G (p.K457E) alteration is located in exon 3 (coding exon 2) of the HR gene. This alteration results from a A to G substitution at nucleotide position 1369, causing the lysine (K) at amino acid position 457 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |